Veterinary Vaccines

Considerable progress has been made in the production of veterinary vaccines whether live or inactivated for animal use during the past two decades with the increasing use of continuous cell lines as a substrate and adoption of the fermentor technology for antigen production. These vaccines are produced for administration to domestic animals or wild species by parenteral or oral routes according to vaccine characteristics. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parentally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA. Trials are under way for the oral immunization of dogs in developing countries.

  • Second-generation veterinary vaccines
  • Highly immunogenic inactivated cell culture vaccines
  • Third generation of live rabies vaccines
  • live or inactivated veterinary vaccines
  • Veterinary vaccines for parenteral use
  • Modified live-virus veterinary vaccines for oral immunization of wildlife
  • Recombinant veterinary vaccines for oral immunization of wildlife

Related Conference of Veterinary Vaccines

May 30-31, 2024

World congress on Immunology and Virology Diseases

Vienna, Austria
August 01-02, 2024

44th Global Summit and Expo on Vaccines & Immunology

Montreal, Canada
September 09-10, 2024

4th International Conference on Vaccine Research

Madrid, Spain
November 28-29, 2024

6th World Congress on Vaccine and Immunology

Paris, France

Veterinary Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in